Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - CEL SCI CORP | cvm_s1.htm |
| EX-23.2 - CONSENT OF BDO USA, LLP - CEL SCI CORP | cvm_ex232.htm |
| EX-23.1 - CONSENT OF HART & HART, LLC - CEL SCI CORP | cvm_ex231.htm |
| EX-10.11 - SECURITIES PURCHASE AGREEMENT WITH ERGOMED - CEL SCI CORP | cvm_ex1011.htm |
| EX-10.10 - WARRANT SOLICITATION AGREEMENT WITH DAWSON JAMES SECURITIES, INC. - CEL SCI CORP | cvm_ex1010.htm |
Exhibit 5
HART & HART, LLC
ATTORNEYS
AT LAW
1624
Washington Street
Denver,
CO 80203
|
William
T. Hart, P.C.
|
Email: harttrinen@aol.com
|
|
Will
Hart
|
Facsimile:
(303) 839-5414
|
(303)
839-0061
July 2,
2020
CEL-SCI Corporation
8229 Boone Blvd. #802
Vienna, Virginia 22182
By
means of this prospectus, certain warrant holders of CEL-SCI
Corporation (the “Company”) are offering to sell up to
563,792 shares of the Company’s common stock which are
issuable upon the exercise of warrants and a shareholder of the
Company is offering 50,000 shares of the Company’s common
stock which were issued in partial payment of amounts the Company
owed to the shareholder for services provided in connection with
the Company’s Phase III clinical trial.
We have
examined the Articles of Incorporation, the Bylaws, and the minutes
of the Board of Directors of the Company, and the applicable laws
of the State of Colorado applicable provisions of the Colorado
Revised Statutes and the Colorado Constitution, all reported
judicial decisions interpreting the same, and copy of the
Registration Statement.
In our
opinion, any shares issued upon the exercise of the warrants, if
exercised in accordance with their terms, will be legally issued
and will represent fully paid and non-assessable shares of the
Company’s common stock and the 50,000 shares of the
Company’s common stock referred to above are legally issued,
fully paid and non-assessable shares of the Company’s common
stock..
Very
truly yours,
HART
& HART
/s/ William T. Hart
William
T. Hart